• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Frontiers in Public Health >Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets
【24h】

Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets

机译：获得新药的障碍：寻找成本上涨与预算有限之间的平衡

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Introduction: There is continued unmet medical need for new medicines across countries especially for cancer, immunological diseases, and orphan diseases. However, there are growing challenges with funding new medicines at ever increasing prices along with funding increased medicine volumes with the growth in both infectious diseases and non-communicable diseases across countries. This has resulted in the development of new models to better manage the entry of new medicines, new financial models being postulated to finance new medicines as well as strategies to improve prescribing efficiency. However, more needs to be done. Consequently, the primary aim of this paper is to consider potential ways to optimize the use of new medicines balancing rising costs with increasing budgetary pressures to stimulate debate especially from a payer perspective.
机译：简介：各国对新药的需求仍未得到满足，特别是针对癌症，免疫疾病和孤儿疾病的新药。然而，随着各国传染病和非传染性疾病的增加，以不断上涨的价格为新药提供资金以及为增加药量提供资金的挑战越来越大。这导致了开发新模型以更好地管理新药的进入，为新药筹集资金的新财务模型以及提高处方效率的策略。但是，还需要做更多的工作。因此，本文的主要目的是考虑潜在的方法，以优化新药的使用，以平衡成本上升和预算压力的增加，以引起辩论，尤其是从付款人的角度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号